Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangkai Fu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 1, 2025
Restoring the enteric neuroimmune crosstalk via hollow mesoporous polydopamine nanoparticles in inflammatory bowel disease treatmentHao Ren, Jiaqi Guo, Chenyu Lu, et al.
Bioscience Trends|February 7, 2024
Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristicsJiayi Wu, Junyi Wu, Shuqun Li, et al.
ACS Applied Materials & Interfaces|March 28, 2025
Promote Sepsis Recovery through the Inhibition of Immunothrombosis via a Combination of Probenecid Nanocrystals and Cefotaxime SodiumZhengjie Meng, Haixiao Huang, Jiaqi Guo, et al.
Cancer Research and Treatment|May 2, 2024
Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter StudyXiangye Ou, Junyi Wu, Jiayi Wu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 1, 2025
Restoring the enteric neuroimmune crosstalk via hollow mesoporous polydopamine nanoparticles in inflammatory bowel disease treatmentHao Ren, Jiaqi Guo, Chenyu Lu, et al.
Bioscience Trends|February 7, 2024
Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristicsJiayi Wu, Junyi Wu, Shuqun Li, et al.
ACS Applied Materials & Interfaces|March 28, 2025
Promote Sepsis Recovery through the Inhibition of Immunothrombosis via a Combination of Probenecid Nanocrystals and Cefotaxime SodiumZhengjie Meng, Haixiao Huang, Jiaqi Guo, et al.
Cancer Research and Treatment|May 2, 2024
Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter StudyXiangye Ou, Junyi Wu, Jiayi Wu, et al.
Pageof 2